CYTK FY 2014 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$47M+53.2% YoY

Gross Profit

$3M5.4% margin

Operating Income

-$15M-31.4% margin

Net Income

-$15M-31.2% margin

EPS (Diluted)

$-0.41

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$46M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$133M

Total Liabilities

$41M

Stockholders' Equity

$92M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$31M	+53.2%
Gross Profit	$3M	-$19M	+113.4%
Operating Income	-$15M	-$34M	+56.5%
Net Income	-$15M	-$34M	+56.6%